Learn how AI is transforming predictions of drug-induced liver injury and aiding drug development for safer therapeutics.

“The projects awarded pilot studies grants for 2026 address important clinical and translational science questions,” says CTSI Director Sanjay Sethi, MD, SUNY Distinguished Professor of medicine and ...

Sensorineural hearing loss (SNHL) is a highly prevalent sensory disorder globally, affecting over 1.5 billion people, with a ...

ILMN's Connected Multiomics, launched after early user input, advances precision health research and may boost the stock.

Multiple sclerosis (MS) is a chronic neurological disease characterized by nerve damage and consequent impairments in vision, ...

Illumina, whose EMEA head office is at Granta Park in Cambridge, has released Illumina Connected Multiomics, a powerful cloud ...

Researchers developed two computational tools to decode how cells communicate in tissues. sCCIgen creates realistic virtual ...

Illumina, Inc. (NASDAQ: ILMN) today announced the release of Illumina Connected Multiomics, a powerful cloud-based research ...

A research team at the Hebrew University has shown that bacteria can survive antibiotic exposure via two distinct ...

Explore how AI-driven multiomics is reshaping drug discovery and personalized medicine development through innovative data ...

The preprint is available here. DeepSpot2Cell predicts virtual single-cell spatial transcriptomics as follows: (1) During training, the model takes as input (i) the cropped cell tile defined by the ...